Mia C. Santucci, BA

Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

  • 2Articles
  • 12.1KReads
  • 2024–2026Active
  • 16Collaborators
  • 16Citations

About

Mia C. Santucci, BA, is affiliated with the Yale Depression Research Program in the Department of Psychiatry at Yale School of Medicine. Santucci has published research on the use of ketamine and esketamine in the treatment of bipolar depression and major depressive disorder, with a focus on psychotherapy interventions such as cognitive behavioral therapy for relapse prevention and the safety and efficacy of these treatments. The work spans topics including bipolar disorder, depression, psychotherapy, and suicide.

Publications

JCP
CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
JCP
Ketamine/Esketamine in Bipolar Depression in a Clinical Setting

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.